CNBX Pharmaceuticals Inc. is a clinical stage pharmaceutical company primarily focused on the development of novel cannabinoid-based products and innovative technologies for the treatment of cancer.
Company profile
Ticker
CNBX
Exchange
Website
CEO
Eyal Barad
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
American Mining Corp, Cannabics Pharmaceuticals Inc., Thrust Energy Corp.
SEC CIK
Corporate docs
IRS number
203373669
CNBX stock data
Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
16 Apr 24
NT 10-Q
Notice of late quarterly filing
15 Apr 24
8-K
Changes in Registrant's Certifying Accountant
22 Mar 24
10-Q
2024 Q1
Quarterly report
12 Jan 24
10-K
2023 FY
Annual report
29 Nov 23
10-Q
2023 Q3
Quarterly report
14 Jul 23
10-Q
2023 Q2
Quarterly report
14 Apr 23
8-K
Departure of Directors or Certain Officers
8 Feb 23
10-Q
2023 Q1
Quarterly report
13 Jan 23
8-K
Departure of Directors or Certain Officers
29 Dec 22
Latest ownership filings
SC 13G/A
3i, LP
13 Feb 24
SC 13G
3i, LP
6 Mar 23
SC 13G
Wize Pharma, Inc.
27 Mar 19
3
SEEDO CORP.
4 Feb 19
144
Notice of proposed sale of securities
21 Dec 16
SC 13D
Cannabics Pharmaceuticals Inc.
25 Jun 14
SC 13D/A
Cannabics Pharmaceuticals Inc.
25 Jun 14
SC 13D/A
American Mining Corp
1 May 14
SC 13D/A
American Mining Corp
25 Nov 13
SC 13D/A
American Mining Corp
4 Nov 13
Financial summary
Quarter (USD) | Nov 23 | Aug 23 | May 23 | Feb 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Aug 23 | Aug 22 | Aug 21 | Aug 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 81.65 k | 81.65 k | 81.65 k | 81.65 k | 81.65 k | 81.65 k |
Cash burn (monthly) | 16.02 k | (no burn) | 57.30 k | 63.04 k | 23.95 k | 7.37 k |
Cash used (since last report) | 74.07 k | n/a | 264.98 k | 291.53 k | 110.75 k | 34.09 k |
Cash remaining | 7.58 k | n/a | -183.34 k | -209.88 k | -29.10 k | 47.56 k |
Runway (months of cash) | 0.5 | n/a | -3.2 | -3.3 | -1.2 | 6.5 |
Institutional ownership, Q4 2022
0.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 824.00 k |
Total shares | 238.98 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
3i | 238.98 k | $824.00 k |
News
Cannabis Stock Gainers And Losers From April 16, 2024
16 Apr 24
Bearish Monday For Marijuana Stocks - AusCann Group Holdings, Target Group Among Top Gainers
15 Apr 24
Cannabis Stock Movers For April 12, 2024
12 Apr 24
Marijuana Stock Movers For April 11, 2024
11 Apr 24
Cannabis Stock Movers For April 10, 2024
10 Apr 24